<?xml version="1.0" encoding="UTF-8" ?> 
<root> 
<TEXT type="str">Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) saw a large decline in short interest during the month of January. As of January 13th, there was short interest totalling 1,654,835 shares, a decline of 31.4% from the December 30th total of 2,413,050 shares. Approximately 12.7% of the company’s shares are sold short. Based on an average trading volume…</TEXT> 
<TOPICS type="list"> 
<item type="dict"> 
<group type="str">Industry</group> 
<name type="str">Pharma industry news</name> 
</item> 
<item type="dict"> 
<group type="str">Finance</group> 
<name type="str">Finance latest</name> 
</item> 
</TOPICS> 
<DOCID type="str">695198203442</DOCID> 
<DCT type="str">2017-01-29T07:42:08Z</DCT> 
<TITLE type="str">Aurinia Pharmaceuticals Inc (AUPH) Short Interest Down 31.4% in January</TITLE> 
</root>